Common Use
Procoralan (ivabradine) is a selective heart rate-lowering medication primarily prescribed for the treatment of chronic stable angina pectoris and symptomatic chronic heart failure with reduced ejection fraction (HFrEF). Ivabradine works through a unique mechanism, selectively inhibiting the If (funny) current in the sinoatrial node, which slows the heart rate without affecting blood pressure, myocardial contractility, or cardiac conduction. By reducing heart rate, Procoralan decreases myocardial oxygen demand, thereby relieving angina symptoms such as chest pain, tightness, and fatigue during physical exertion. For heart failure patients, this medication helps improve cardiac function, reduce hospitalizations, and enhance exercise tolerance. Procoralan is typically prescribed when beta-blockers alone are insufficient or cannot be tolerated. Patients who buy Procoralan online appreciate its targeted mechanism that addresses heart rate without the broader cardiovascular effects of traditional beta-blockers.

Dosage and Direction
The usual starting adult dose of Procoralan is 5 mg taken twice daily with meals, as food increases absorption by approximately 20-30%. After 3-4 weeks, your doctor may increase the dose to 7.5 mg twice daily based on your resting heart rate response and symptom improvement. If your heart rate drops below 50 bpm or you experience symptoms of bradycardia, the dose may be reduced to 2.5 mg twice daily or the medication discontinued. Take Procoralan at the same times every day, typically with breakfast and dinner. Do not stop the medication suddenly without your doctor's advice, as gradual tapering may be recommended.

Precautions
Before starting Procoralan, inform your doctor if you have low blood pressure, bradycardia (resting heart rate below 70 bpm), sick sinus syndrome, sinoatrial block, congenital QT prolongation, retinitis pigmentosa, liver problems, or severe kidney impairment. Regular heart rate monitoring is strongly recommended throughout treatment, especially during the first weeks and after dose adjustments. Avoid consuming grapefruit and grapefruit juice during treatment, as they can significantly increase ivabradine levels. Limit or avoid alcohol consumption. Ivabradine may cause temporary visual disturbances (phosphenes or luminous phenomena), particularly in low-light conditions; use caution when driving at night.

Contraindications
Do not use Procoralan if you have severe bradycardia (resting heart rate below 70 bpm before treatment initiation), acute decompensated heart failure, cardiogenic shock, severe hypotension (blood pressure below 90/50 mmHg), sick sinus syndrome, sinoatrial block, third-degree AV block, unstable angina, or pacemaker dependence. Ivabradine is contraindicated in patients with known hypersensitivity to the active substance or any excipient. Co-administration with strong CYP3A4 inhibitors such as ketoconazole, itraconazole, or HIV protease inhibitors is contraindicated. Procoralan must not be used during pregnancy or breastfeeding, as ivabradine may cause fetal harm.

Possible Side Effects
Common side effects of Procoralan include bradycardia (excessively slow heart rate), dizziness, headache, fatigue, and visual disturbances known as phosphenes (brief episodes of enhanced brightness in a limited area of the visual field, often triggered by sudden changes in light intensity). These visual phenomena are generally mild, transient, and fully reversible upon discontinuation. Less common side effects include atrial fibrillation, nausea, constipation, diarrhea, or blurred vision. Serious adverse reactions may include severe bradycardia, heart rhythm abnormalities, or syncope (fainting). Contact your doctor immediately if you experience any unusual cardiac symptoms.

Drug Interaction
Procoralan can interact with strong CYP3A4 inhibitors (such as ketoconazole, itraconazole, clarithromycin, josamycin, and HIV protease inhibitors) and moderate CYP3A4 inhibitors (such as diltiazem, verapamil, and fluconazole), which can substantially increase ivabradine blood levels and enhance side effects. CYP3A4 inducers such as rifampicin, phenytoin, barbiturates, and St. John's Wort may reduce ivabradine effectiveness. Combining Procoralan with other heart rate-lowering drugs (beta-blockers, non-dihydropyridine calcium channel blockers, digoxin) may increase the risk of excessive bradycardia. QT-prolonging medications should be used with caution. Always inform your doctor about all medications, supplements, and herbal products you are taking.

Missed Dose
If a dose of Procoralan is missed, take it as soon as you remember with your next meal. If it is near the time of the next dose, skip the missed dose and continue your regular twice-daily schedule. Do not double the dose to compensate, as this may cause excessive heart rate lowering.

Overdose
Overdose of Procoralan may cause severe and potentially prolonged bradycardia, hypotension, or serious heart rhythm disturbances. Seek immediate emergency medical attention if an overdose is suspected. There is no specific antidote for ivabradine. Emergency treatment may include atropine, isoprenaline, temporary cardiac pacing, continuous heart monitoring, and supportive cardiovascular care.

Storage
Store Procoralan at room temperature between 15-25 degrees C (59-77 degrees F), away from moisture, heat, and direct sunlight. Keep the medication in its original packaging. Keep out of reach of children and pets. Do not use Procoralan past its expiration date.

Disclaimer

We provide only general information about medications which does not cover all directions, possible drug integrations, or precautions. Information at the site cannot be used for self-treatment and self-diagnosis. Any specific instructions for a particular patient should be agreed with your health care adviser or doctor in charge of the case. We disclaim reliability of this information and mistakes it could contain. We are not responsible for any direct, indirect, special or other indirect damage as a result of any use of the information on this site and also for consequences of self-treatment.